FBIO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Fortress Biotech Inc (FBIO) is not a strong buy at this moment for a beginner investor with a long-term focus. While the company has shown revenue growth, the significant decline in net income, EPS, and gross margin raises concerns about its financial health. The technical indicators and options data suggest a neutral to bearish sentiment, and there are no recent positive catalysts or influential trades to support a buy decision. Holding off on investment until clearer positive signals emerge would be prudent.
The MACD is negatively expanding, indicating bearish momentum. RSI is at 27.292, which is neutral but nearing oversold territory. Moving averages are converging, and the stock is trading near its support level (S1: 2.818). Overall, the technical indicators suggest a weak trend with no clear bullish signals.
Revenue increased by 20.52% YoY in Q3 2025, showing some growth potential.
Net income dropped by -124.43% YoY, EPS fell by -114.47% YoY, and gross margin decreased by -3.99% YoY. No recent news or significant trading trends from insiders, hedge funds, or Congress. Technical indicators are weak, and the stock has a 60% chance to decline in the next day and month.
In Q3 2025, revenue grew to $17.63M (up 20.52% YoY), but net income dropped significantly to $3.68M (-124.43% YoY). EPS also declined to 0.11 (-114.47% YoY), and gross margin fell to 61.32% (-3.99% YoY). These metrics indicate financial struggles despite revenue growth.
No recent analyst ratings or price target changes available for FBIO.
